[M03AB01, succinylcholine, Succinylcholine may increase the neurotoxic activities of Imipenem.]
[N05AL01, sulpiride, Sulpiride may increase the neurotoxic activities of Imipenem.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Imipenem.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Imipenem.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Tetracaine.]
[N05AE05, lurasidone, Imipenem may increase the neurotoxic activities of Lurasidone.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the neurotoxic activities of Imipenem.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Imipenem.]
[N05AB08, thioproperazine, Imipenem may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the neurotoxic activities of Imipenem.]
[N05AF04, thiothixene, Imipenem may increase the neurotoxic activities of Thiothixene.]
[N05AL03, tiapride, Imipenem may increase the neurotoxic activities of Tiapride.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the neurotoxic activities of Imipenem.]
[N05AD02, trifluperidol, Imipenem may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Triflupromazine may increase the neurotoxic activities of Imipenem.]
[R06AD01, trimeprazine, Alimemazine may increase the neurotoxic activities of Imipenem.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be decreased when used in combination with Imipenem.]
[N06AA06, trimipramine, Trimipramine may increase the neurotoxic activities of Imipenem.]
[M03AA02, tubocurarine, Tubocurarine may increase the neurotoxic activities of Imipenem.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be decreased when used in combination with Imipenem.]
[L01CA02, vincristine, Vincristine may increase the neurotoxic activities of Imipenem.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Imipenem is combined with Warfarin.]
[N05AF05, zuclopenthixol, Imipenem may increase the neurotoxic activities of Zuclopenthixol.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Imipenem.]
[N05AE04, ziprasidone, Ziprasidone may increase the neurotoxic activities of Imipenem.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Imipenem.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Imipenem.]
[N01AA01, ethyl ether, Imipenem may increase the neurotoxic activities of Diethyl ether.]
[N05AD07, benperidol, Imipenem may increase the neurotoxic activities of Benperidol.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Benzyl alcohol.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Imipenem.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Imipenem.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Imipenem is combined with Acenocoumarol.]
[N03AG01, valproic acid, The therapeutic efficacy of Valproic acid can be decreased when used in combination with Imipenem.]
[N05AA04, acepromazine, Imipenem may increase the neurotoxic activities of Acepromazine.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Imipenem is combined with Dicoumarol.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Imipenem is combined with Tioclomarol.]
[N05AX16, brexpiprazole, Imipenem may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Imipenem may increase the neurotoxic activities of Cariprazine.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Imipenem.]
[N05AB07, acetophenazine, Acetophenazine may increase the neurotoxic activities of Imipenem.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Imipenem.]
[N06AA19, amineptin, Imipenem may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Imipenem may increase the neurotoxic activities of Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Bupivacaine.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be decreased when used in combination with Imipenem.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Imipenem.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Oxybuprocaine.]
[A02BX12, bismuth subnitrate, Imipenem may increase the neurotoxic activities of Bismuth subnitrate.]
[N05AD06, bromperidol, Imipenem may increase the neurotoxic activities of Bromperidol.]
[N06AA15, butriptyline, Imipenem may increase the neurotoxic activities of Butriptyline.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Capsaicin.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Imipenem.]
[N03AX24, cannabidiol, The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Imipenem.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Imipenem.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Chloroprocaine.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Imipenem is combined with Amifampridine.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Imipenem.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Imipenem.]
[N05AA06, cyamemazine, Imipenem may increase the neurotoxic activities of Cyamemazine.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the neurotoxic activities of Imipenem.]
[N03AX25, cenobamate, The therapeutic efficacy of Cenobamate can be decreased when used in combination with Imipenem.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Imipenem.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Imipenem.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Dyclonine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the neurotoxic activities of Imipenem.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the neurotoxic activities of Imipenem.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Imipenem.]
[L01FX21, naxitamab, Imipenem may increase the neurotoxic activities of Naxitamab.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be decreased when used in combination with Imipenem.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Imipenem.]
[J01FF01, clindamycin, Clindamycin may increase the neurotoxic activities of Imipenem.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may increase the neurotoxic activities of Imipenem.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Imipenem.]
[N05AH06, clothiapine, Imipenem may increase the neurotoxic activities of Clothiapine.]
[N05AH02, clozapine, Clozapine may increase the neurotoxic activities of Imipenem.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Cocaine.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Imipenem.]
[J05AB14, valganciclovir, The risk or severity of generalized seizure can be increased when Valganciclovir is combined with Imipenem.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Imipenem.]
[N05AD03, metylperon, Imipenem may increase the neurotoxic activities of Melperone.]
[L01AA01, cyclophosphamide, Cyclophosphamide may increase the neurotoxic activities of Imipenem.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Imipenem.]
[S01XA18, cyclosporine, Cyclosporine may increase the neurotoxic activities of Imipenem.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Imipenem.]
[M03AC11, cisatracurium, Imipenem may increase the neuromuscular blocking activities of Cisatracurium.]
[N06AA01, desipramine, Desipramine may increase the neurotoxic activities of Imipenem.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Imipenem.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be decreased when used in combination with Imipenem.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Imipenem.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Imipenem.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Imipenem.]
[N06AA08, dibenzepin, Imipenem may increase the neurotoxic activities of Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Cinchocaine.]
[J05AF02, didanosine, Didanosine may increase the neurotoxic activities of Imipenem.]
[N05AD05, pipamperone, Imipenem may increase the neurotoxic activities of Pipamperone.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Pramocaine.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Imipenem.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Diphenhydramine.]
[N06AA23, quinupramine, Imipenem may increase the neurotoxic activities of Quinupramine.]
[N05AL04, remoxipride, Remoxipride may increase the neurotoxic activities of Imipenem.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Imipenem.]
[N05AX08, risperidone, Risperidone may increase the neurotoxic activities of Imipenem.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Ropivacaine.]
[N06AA16, dothiepin, Imipenem may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Doxepin may increase the neurotoxic activities of Imipenem.]
[N05AD08, droperidol, Droperidol may increase the neurotoxic activities of Imipenem.]
[N05AL02, sultopride, Imipenem may increase the neurotoxic activities of Sultopride.]
[N05AB05, thiopropazate, Imipenem may increase the neurotoxic activities of Thiopropazate.]
[N06AX14, tianeptine, Imipenem may increase the neurotoxic activities of Tianeptine.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Imipenem.]
[N05AL06, veralipride, Imipenem may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Imipenem.]
[N03AX15, zonisamide, The therapeutic efficacy of Zonisamide can be decreased when used in combination with Imipenem.]
[N05AX11, zotepine, Imipenem may increase the neurotoxic activities of Zotepine.]
[C01BG01, moricizine, Moricizine may increase the neurotoxic activities of Imipenem.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Imipenem.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Imipenem.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Imipenem.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Etidocaine.]
[N05AE03, sertindole, Imipenem may increase the neurotoxic activities of Sertindole.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Imipenem.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Imipenem.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be decreased when used in combination with Imipenem.]
[N06AA14, melitracen, Imipenem may increase the neurotoxic activities of Melitracen.]
[V03AZ01, ethanol, Ethanol may increase the neurotoxic activities of Imipenem.]
[N05AF01, flupenthixol, Flupentixol may increase the neurotoxic activities of Imipenem.]
[N05AB02, fluphenazine, Fluphenazine may increase the neurotoxic activities of Imipenem.]
[N05AG01, fluspirilene, Imipenem may increase the neurotoxic activities of Fluspirilene.]
[N05AL05, amisulpride, Imipenem may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, Imipenem may increase the neurotoxic activities of Gallamine.]
[S01AD09, ganciclovir, The risk or severity of generalized seizure can be increased when Ganciclovir is combined with Imipenem.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Imipenem.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be decreased when used in combination with Imipenem.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Imipenem is combined with Fluindione.]
[N05AD01, haloperidol, Haloperidol may increase the neurotoxic activities of Imipenem.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Imipenem.]
[N05AX07, prothipendyl, Imipenem may increase the neurotoxic activities of Prothipendyl.]
[B05CB02, sodium citrate, Imipenem may increase the neurotoxic activities of Sodium citrate.]
[N06AA02, imipramine, Imipramine may increase the neurotoxic activities of Imipenem.]
[L01CD01, paclitaxel, Paclitaxel may increase the neurotoxic activities of Imipenem.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Imipenem.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Articaine.]
[J05AF04, stavudine, Stavudine may increase the neurotoxic activities of Imipenem.]
[N06AA13, iprindole, Imipenem may increase the neurotoxic activities of Iprindole.]
[N05AA07, chlorproethazine, Imipenem may increase the neurotoxic activities of Chlorproethazine.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be decreased when used in combination with Imipenem.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Lidocaine.]
[J01FF02, lincomycin, Imipenem may increase the neurotoxic activities of Lincomycin.]
[N06AA07, lofepramine, Imipenem may increase the neurotoxic activities of Lofepramine.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Imipenem.]
[N05AH01, loxapine, Loxapine may increase the neurotoxic activities of Imipenem.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Imipenem.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Imipenem.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Imipenem.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Imipenem.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Mepivacaine.]
[N05AC03, mesoridazine, Mesoridazine may increase the neurotoxic activities of Imipenem.]
[N05AX13, paliperidone, Paliperidone may increase the neurotoxic activities of Imipenem.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Imipenem.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Imipenem.]
[N05AA02, methotrimeprazine, Methotrimeprazine may increase the neurotoxic activities of Imipenem.]
[V04CG05, methylene blue, Imipenem may increase the neurotoxic activities of Methylene blue.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Imipenem.]
[N05AE02, molindone, Imipenem may increase the neurotoxic activities of Molindone.]
[N06AA09, amitriptyline, Amitriptyline may increase the neurotoxic activities of Imipenem.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Imipenem.]
[N06AA17, amoxapine, Amoxapine may increase the neurotoxic activities of Imipenem.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Imipenem.]
[S03AA01, neomycin, Neomycin may increase the neurotoxic activities of Imipenem.]
[N05AX14, iloperidone, Imipenem may increase the neurotoxic activities of Iloperidone.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Imipenem.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Imipenem.]
[N06AA10, nortriptyline, Nortriptyline may increase the neurotoxic activities of Imipenem.]
[N06AA05, opipramol, Imipenem may increase the neurotoxic activities of Opipramol.]
[N05AE01, oxypertine, Imipenem may increase the neurotoxic activities of Oxypertine.]
[N05AH05, asenapine, Imipenem may increase the neurotoxic activities of Asenapine.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Imipenem.]
[N05AG03, penfluridol, Imipenem may increase the neurotoxic activities of Penfluridol.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Imipenem.]
[N05AB10, perazine, Imipenem may increase the neurotoxic activities of Perazine.]
[N05AB03, perphenazine, Perphenazine may increase the neurotoxic activities of Imipenem.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Imipenem is combined with Phenindione.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Imipenem.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Imipenem is combined with Phenprocoumon.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Imipenem.]
[N05AG02, pimozide, Pimozide may increase the neurotoxic activities of Imipenem.]
[N05AC04, pipothiazine, Imipenem may increase the neurotoxic activities of Pipotiazine.]
[S03AA03, polymyxin B, Imipenem may increase the neurotoxic activities of Polymyxin B.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Prilocaine.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be decreased when used in combination with Imipenem.]
[M04AB01, probenecid, The serum concentration of Imipenem can be increased when it is combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Procaine.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the neurotoxic activities of Imipenem.]
[N05AA03, promazine, Promazine may increase the neurotoxic activities of Imipenem.]
[R06AD02, promethazine, Promethazine may increase the neurotoxic activities of Imipenem.]
[N05AC01, periciazine, Imipenem may increase the neurotoxic activities of Periciazine.]
[N06AA11, protriptyline, Protriptyline may increase the neurotoxic activities of Imipenem.]
[N05AX12, aripiprazole, Aripiprazole may increase the neurotoxic activities of Imipenem.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Imipenem is combined with Dalfampridine.]
[C02AA02, reserpine, Reserpine may increase the neurotoxic activities of Imipenem.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Imipenem.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Cilastatin.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Cilastatin.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Cilastatin.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Cilastatin.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Cilastatin.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Cilastatin.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Cilastatin.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Cilastatin.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Cilastatin.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Cilastatin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Cilastatin.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Cilastatin.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Cilastatin.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Cilastatin.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Cilastatin.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Cilastatin.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Cilastatin.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Cilastatin.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Cilastatin.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Cilastatin.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Cilastatin.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Cilastatin.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Cilastatin.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Cilastatin.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Cilastatin.]
[S01XA18, cyclosporine, The excretion of Cyclosporine can be increased when combined with Cilastatin.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Cilastatin.]
[S03BA01, dexamethasone, The excretion of Dexamethasone can be decreased when combined with Cilastatin.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Cilastatin.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Cilastatin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Cilastatin.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Cilastatin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Cilastatin.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Cilastatin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cilastatin.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Cilastatin.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Cilastatin.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Cilastatin.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Cilastatin.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Cilastatin.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Cilastatin.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Cilastatin.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Cilastatin.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Cilastatin.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Cilastatin.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Cilastatin.]
[J05AF05, lamivudine, The excretion of Lamivudine can be decreased when combined with Cilastatin.]
[L01BA04, pemetrexed, Cilastatin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Cilastatin.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Cilastatin.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Cilastatin.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Cilastatin.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Cilastatin.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Cilastatin.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Cilastatin.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Cilastatin.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Cilastatin.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Cilastatin.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Cilastatin.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Cilastatin.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Cilastatin.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Cilastatin.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Cilastatin.]
[M03AB01, succinylcholine, Succinylcholine may increase the neurotoxic activities of Imipenem.]
[N05AL01, sulpiride, Sulpiride may increase the neurotoxic activities of Imipenem.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Imipenem.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Imipenem.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Tetracaine.]
[N05AE05, lurasidone, Imipenem may increase the neurotoxic activities of Lurasidone.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the neurotoxic activities of Imipenem.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Imipenem.]
[N05AB08, thioproperazine, Imipenem may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the neurotoxic activities of Imipenem.]
[N05AF04, thiothixene, Imipenem may increase the neurotoxic activities of Thiothixene.]
[N05AL03, tiapride, Imipenem may increase the neurotoxic activities of Tiapride.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the neurotoxic activities of Imipenem.]
[N05AD02, trifluperidol, Imipenem may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Triflupromazine may increase the neurotoxic activities of Imipenem.]
[R06AD01, trimeprazine, Alimemazine may increase the neurotoxic activities of Imipenem.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be decreased when used in combination with Imipenem.]
[N06AA06, trimipramine, Trimipramine may increase the neurotoxic activities of Imipenem.]
[M03AA02, tubocurarine, Tubocurarine may increase the neurotoxic activities of Imipenem.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be decreased when used in combination with Imipenem.]
[L01CA02, vincristine, Vincristine may increase the neurotoxic activities of Imipenem.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Imipenem is combined with Warfarin.]
[N05AF05, zuclopenthixol, Imipenem may increase the neurotoxic activities of Zuclopenthixol.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Imipenem.]
[N05AE04, ziprasidone, Ziprasidone may increase the neurotoxic activities of Imipenem.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Imipenem.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Imipenem.]
[N01AA01, ethyl ether, Imipenem may increase the neurotoxic activities of Diethyl ether.]
[N05AD07, benperidol, Imipenem may increase the neurotoxic activities of Benperidol.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Benzyl alcohol.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Imipenem.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Imipenem.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Imipenem is combined with Acenocoumarol.]
[N05AA04, acepromazine, Imipenem may increase the neurotoxic activities of Acepromazine.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Imipenem is combined with Dicoumarol.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Imipenem is combined with Tioclomarol.]
[N05AX16, brexpiprazole, Imipenem may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Imipenem may increase the neurotoxic activities of Cariprazine.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Imipenem.]
[N05AB07, acetophenazine, Acetophenazine may increase the neurotoxic activities of Imipenem.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Imipenem.]
[N06AA19, amineptin, Imipenem may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Imipenem may increase the neurotoxic activities of Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Bupivacaine.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be decreased when used in combination with Imipenem.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Imipenem.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Oxybuprocaine.]
[A02BX12, bismuth subnitrate, Imipenem may increase the neurotoxic activities of Bismuth subnitrate.]
[N05AD06, bromperidol, Imipenem may increase the neurotoxic activities of Bromperidol.]
[N06AA15, butriptyline, Imipenem may increase the neurotoxic activities of Butriptyline.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Capsaicin.]
[N03AF01, carbamazepine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Imipenem.]
[N03AX24, cannabidiol, The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Imipenem.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Imipenem.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Chloroprocaine.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Imipenem is combined with Amifampridine.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Imipenem.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Imipenem.]
[N05AA06, cyamemazine, Imipenem may increase the neurotoxic activities of Cyamemazine.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the neurotoxic activities of Imipenem.]
[N03AX25, cenobamate, The therapeutic efficacy of Cenobamate can be decreased when used in combination with Imipenem.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Imipenem.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Imipenem.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Dyclonine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the neurotoxic activities of Imipenem.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the neurotoxic activities of Imipenem.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Imipenem.]
[L01FX21, naxitamab, Imipenem may increase the neurotoxic activities of Naxitamab.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be decreased when used in combination with Imipenem.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Imipenem.]
[J01FF01, clindamycin, Clindamycin may increase the neurotoxic activities of Imipenem.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may increase the neurotoxic activities of Imipenem.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Imipenem.]
[N05AH06, clothiapine, Imipenem may increase the neurotoxic activities of Clothiapine.]
[N05AH02, clozapine, Clozapine may increase the neurotoxic activities of Imipenem.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Cocaine.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Imipenem.]
[J05AB14, valganciclovir, The risk or severity of generalized seizure can be increased when Valganciclovir is combined with Imipenem.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Imipenem.]
[N05AD03, metylperon, Imipenem may increase the neurotoxic activities of Melperone.]
[L01AA01, cyclophosphamide, Cyclophosphamide may increase the neurotoxic activities of Imipenem.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Imipenem.]
[S01XA18, cyclosporine, Cyclosporine may increase the neurotoxic activities of Imipenem.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Imipenem.]
[M03AC11, cisatracurium, Imipenem may increase the neuromuscular blocking activities of Cisatracurium.]
[N06AA01, desipramine, Desipramine may increase the neurotoxic activities of Imipenem.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Imipenem.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be decreased when used in combination with Imipenem.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Imipenem.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Imipenem.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Imipenem.]
[N06AA08, dibenzepin, Imipenem may increase the neurotoxic activities of Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Cinchocaine.]
[J05AF02, didanosine, Didanosine may increase the neurotoxic activities of Imipenem.]
[N05AD05, pipamperone, Imipenem may increase the neurotoxic activities of Pipamperone.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Pramocaine.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Imipenem.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Diphenhydramine.]
[N06AA23, quinupramine, Imipenem may increase the neurotoxic activities of Quinupramine.]
[N05AL04, remoxipride, Remoxipride may increase the neurotoxic activities of Imipenem.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Imipenem.]
[N05AX08, risperidone, Risperidone may increase the neurotoxic activities of Imipenem.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Ropivacaine.]
[N06AA16, dothiepin, Imipenem may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Doxepin may increase the neurotoxic activities of Imipenem.]
[N05AD08, droperidol, Droperidol may increase the neurotoxic activities of Imipenem.]
[N05AL02, sultopride, Imipenem may increase the neurotoxic activities of Sultopride.]
[N05AB05, thiopropazate, Imipenem may increase the neurotoxic activities of Thiopropazate.]
[N06AX14, tianeptine, Imipenem may increase the neurotoxic activities of Tianeptine.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Imipenem.]
[N05AL06, veralipride, Imipenem may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Imipenem.]
[N03AX15, zonisamide, The therapeutic efficacy of Zonisamide can be decreased when used in combination with Imipenem.]
[N05AX11, zotepine, Imipenem may increase the neurotoxic activities of Zotepine.]
[C01BG01, moricizine, Moricizine may increase the neurotoxic activities of Imipenem.]
[N03AG01, valproic acid, The therapeutic efficacy of Valproic acid can be decreased when used in combination with Imipenem.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Imipenem.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Imipenem.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Imipenem.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Etidocaine.]
[N05AE03, sertindole, Imipenem may increase the neurotoxic activities of Sertindole.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Imipenem.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Imipenem.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be decreased when used in combination with Imipenem.]
[N06AA14, melitracen, Imipenem may increase the neurotoxic activities of Melitracen.]
[V03AZ01, ethanol, Ethanol may increase the neurotoxic activities of Imipenem.]
[N05AF01, flupenthixol, Flupentixol may increase the neurotoxic activities of Imipenem.]
[N05AB02, fluphenazine, Fluphenazine may increase the neurotoxic activities of Imipenem.]
[N05AG01, fluspirilene, Imipenem may increase the neurotoxic activities of Fluspirilene.]
[N05AL05, amisulpride, Imipenem may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, Imipenem may increase the neurotoxic activities of Gallamine.]
[S01AD09, ganciclovir, The risk or severity of generalized seizure can be increased when Ganciclovir is combined with Imipenem.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Imipenem.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be decreased when used in combination with Imipenem.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Imipenem is combined with Fluindione.]
[N05AD01, haloperidol, Haloperidol may increase the neurotoxic activities of Imipenem.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Imipenem.]
[N05AX07, prothipendyl, Imipenem may increase the neurotoxic activities of Prothipendyl.]
[B05CB02, sodium citrate, Imipenem may increase the neurotoxic activities of Sodium citrate.]
[N06AA02, imipramine, Imipramine may increase the neurotoxic activities of Imipenem.]
[L01CD01, paclitaxel, Paclitaxel may increase the neurotoxic activities of Imipenem.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Imipenem.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Articaine.]
[J05AF04, stavudine, Stavudine may increase the neurotoxic activities of Imipenem.]
[N06AA13, iprindole, Imipenem may increase the neurotoxic activities of Iprindole.]
[N05AA07, chlorproethazine, Imipenem may increase the neurotoxic activities of Chlorproethazine.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be decreased when used in combination with Imipenem.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Lidocaine.]
[J01FF02, lincomycin, Imipenem may increase the neurotoxic activities of Lincomycin.]
[N06AA07, lofepramine, Imipenem may increase the neurotoxic activities of Lofepramine.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Imipenem.]
[N05AH01, loxapine, Loxapine may increase the neurotoxic activities of Imipenem.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Imipenem.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Imipenem.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Imipenem.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Imipenem.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Mepivacaine.]
[N05AC03, mesoridazine, Mesoridazine may increase the neurotoxic activities of Imipenem.]
[N05AX13, paliperidone, Paliperidone may increase the neurotoxic activities of Imipenem.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Imipenem.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Imipenem.]
[N05AA02, methotrimeprazine, Methotrimeprazine may increase the neurotoxic activities of Imipenem.]
[V04CG05, methylene blue, Imipenem may increase the neurotoxic activities of Methylene blue.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Imipenem.]
[N05AE02, molindone, Imipenem may increase the neurotoxic activities of Molindone.]
[N06AA09, amitriptyline, Amitriptyline may increase the neurotoxic activities of Imipenem.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Imipenem.]
[N06AA17, amoxapine, Amoxapine may increase the neurotoxic activities of Imipenem.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Imipenem.]
[S03AA01, neomycin, Neomycin may increase the neurotoxic activities of Imipenem.]
[N05AX14, iloperidone, Imipenem may increase the neurotoxic activities of Iloperidone.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Imipenem.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Imipenem.]
[N06AA10, nortriptyline, Nortriptyline may increase the neurotoxic activities of Imipenem.]
[N06AA05, opipramol, Imipenem may increase the neurotoxic activities of Opipramol.]
[N05AE01, oxypertine, Imipenem may increase the neurotoxic activities of Oxypertine.]
[N05AH05, asenapine, Imipenem may increase the neurotoxic activities of Asenapine.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Imipenem.]
[N05AG03, penfluridol, Imipenem may increase the neurotoxic activities of Penfluridol.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Imipenem.]
[N05AB10, perazine, Imipenem may increase the neurotoxic activities of Perazine.]
[N05AB03, perphenazine, Perphenazine may increase the neurotoxic activities of Imipenem.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Imipenem is combined with Phenindione.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Imipenem.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Imipenem is combined with Phenprocoumon.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Imipenem.]
[N05AG02, pimozide, Pimozide may increase the neurotoxic activities of Imipenem.]
[N05AC04, pipothiazine, Imipenem may increase the neurotoxic activities of Pipotiazine.]
[S03AA03, polymyxin B, Imipenem may increase the neurotoxic activities of Polymyxin B.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Prilocaine.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be decreased when used in combination with Imipenem.]
[M04AB01, probenecid, The serum concentration of Imipenem can be increased when it is combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Procaine.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the neurotoxic activities of Imipenem.]
[N05AA03, promazine, Promazine may increase the neurotoxic activities of Imipenem.]
[R06AD02, promethazine, Promethazine may increase the neurotoxic activities of Imipenem.]
[N05AC01, periciazine, Imipenem may increase the neurotoxic activities of Periciazine.]
[N06AA11, protriptyline, Protriptyline may increase the neurotoxic activities of Imipenem.]
[N05AX12, aripiprazole, Aripiprazole may increase the neurotoxic activities of Imipenem.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Imipenem is combined with Dalfampridine.]
[C02AA02, reserpine, Reserpine may increase the neurotoxic activities of Imipenem.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Imipenem.]
